Health Canada Approves Visbiome Probiotic for Irritable Bowel Syndrome
-
October 10, 2017 -
October 5, 2017 PENDOPHARM launches GLATECT, a new treatment option for MS patients
Read More -
September 28, 2017 Introducing the New LAX-A product line for relief of occasional constipation
Read More -
September 28, 2017 With Lax-A-Day, you don’t need to spend your life in the bathroom!
Read More -
September 22, 2017 PENDOPHARM, a division of Pharmascience Inc., Invests in Ontario based Edesa Biotech and Licenses Three Novel Anorectal Treatments for Canada
Read More